Piper Sandler Maintains Overweight on CVS Health, Raises Price Target to $74
CVSMarch 21, 2025
Read more →This Is What Whales Are Betting On CVS Health
CVSMarch 19, 2025
Read more →CVS Stock Flashes Golden Cross As Weight Loss Program Delivers Big Results
CVSCVS Health Corp. flashing bullish signal with Golden Cross formation and strong technicals. Weight management program also gaining traction.
March 17, 2025
Read more →Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
CVSA lawsuit has been lodged against JPMorgan Chase by its employees, who claim that the company's prescription drug plan consented to pay exorbitant prices for medications.
March 15, 2025
Read more →CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
CVSCVS Weight Management program members achieved 15% average weight loss, with 92% satisfaction and 26% lower GLP-1 medication costs for participating clients.
March 14, 2025
Read more →CVS Health Reports Results From CVS Weight Management Program With 15% Average Weight Loss, Including Significant Gains For Anti-Obesity Medication Users
CVSMarch 14, 2025
Read more →Spotlight on CVS Health: Analyzing the Surge in Options Activity
CVSMarch 13, 2025
Read more →Is CVS Health Gaining or Losing Market Support?
CVSMarch 6, 2025
Read more →CVS Health Options Trading: A Deep Dive into Market Sentiment
CVSMarch 6, 2025
Read more →CVS Health Announces That Wellvana Has Acquired The Medicare Shared Savings Program Business Of CVS Accountable Care, Part Of CVS Health, In An All-Stock Transaction; Detailed Terms Have Not Been Disclosed
CVSMarch 4, 2025
Read more →Behind the Scenes of CVS Health's Latest Options Trends
CVSFebruary 26, 2025
Read more →Behind the Scenes of CVS Health's Latest Options Trends
CVSFebruary 21, 2025
Read more →CVS Director, Michael Mahoney, Buys 30,000 Shares At Average Price Of $66.70/Share
CVSFebruary 19, 2025
Read more →JP Morgan Maintains Overweight on CVS Health, Raises Price Target to $81
CVSFebruary 18, 2025
Read more →Third Point Dissolves Share Stake In CVS Health Corp
CVSFebruary 14, 2025
Read more →Beyond The Numbers: 11 Analysts Discuss CVS Health Stock
CVSFebruary 13, 2025
Read more →CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVSCVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.
February 13, 2025
Read more →Wells Fargo Maintains Overweight on CVS Health, Raises Price Target to $73
CVSFebruary 13, 2025
Read more →These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVSFebruary 13, 2025
Read more →Truist Securities Maintains Buy on CVS Health, Raises Price Target to $76
CVSFebruary 13, 2025
Read more →Barclays Maintains Overweight on CVS Health, Raises Price Target to $73
CVSFebruary 13, 2025
Read more →Leerink Partners Upgrades CVS Health to Outperform, Raises Price Target to $75
CVSFebruary 13, 2025
Read more →CVS Health Forecasts 10% Earnings Growth For 2025, Citing Aetna's 'Meaningful Recovery'
CVSCVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — Aetna's turnaround.
February 13, 2025
Read more →Market Whales and Their Recent Bets on CVS Options
CVSFebruary 12, 2025
Read more →Benzinga Market Summary: January Inflation Comes In Above Estimates, CVS Stock Surges On Strong Earnings, Bitcoin And Gold Move Lower as CPI Figures Dampen Rate Cut Outlook
CVSFebruary 12, 2025
Read more →CVS Health Exec Says Although Medical Care Demand Trends Were Elevated, It Was Less Severe Than Assumed; Saw Some Pressure In Its Stop Loss Business
CVSFebruary 12, 2025
Read more →CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVSCVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00.
February 12, 2025
Read more →CVS Health Forecasts FY2025 Adjusted EPS Of $5.75-$6.00 Versus Consensus Of $5.96
CVSFebruary 12, 2025
Read more →CVS Health Q4 2024 Adj EPS $1.19 Beats $0.93 Estimate, Sales $97.71B Beat $97.19B Estimate
CVSFebruary 12, 2025
Read more →What's Going On With CVS, Humana and UnitedHealth Shares Monday?
CVSShares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise to Medicare Advantage payments.
January 13, 2025
Read more →Peering Into CVS Health's Recent Short Interest
CVSDecember 19, 2024
Read more →CVS Shares Are Falling Today: What's Going On?
CVSCVS Health Corporation's stock (NYSE: CVS) is trading lower Thursday amid news of a lawsuit filed by the U.S. Department of Justice (DOJ) against CVS Pharmacy Inc., a subsidiary of CVS Health. Here's what you need to know.
December 19, 2024
Read more →CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
CVSThe U.S. Department of Justice filed a civil complaint against CVS Pharmacy Inc owned by CVS Health Corp, alleging the nation's largest pharmacy chain violated the Controlled Substances Act by filling unlawful prescriptions for dangerous opioid combinations and quantities from 2013 onwards.
December 19, 2024
Read more →Truist Securities Reiterates Buy on CVS Health, Lowers Price Target to $67
CVSNovember 20, 2024
Read more →CVS Health Options Trading: A Deep Dive into Market Sentiment
CVSNovember 19, 2024
Read more →CVS Health Stock Is Moving Higher Monday: What's Going On?
CVSCVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.
November 18, 2024
Read more →Wells Fargo Upgrades CVS Health to Overweight, Raises Price Target to $66
CVSNovember 18, 2024
Read more →CVS Health Adds Four New Directors Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman After Discussing With Glenview Capital Management, Strengthening Board With Industry Veterans
CVSNovember 18, 2024
Read more →Analyst Expectations For CVS Health's Future
CVSNovember 15, 2024
Read more →RBC Capital Maintains Outperform on CVS Health, Lowers Price Target to $58
CVSNovember 15, 2024
Read more →CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit
CVSCVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges.
November 6, 2024
Read more →CVS Executive Says Company Is Not Providing A Formal Outlook For 2024 At This Stage
CVSNovember 6, 2024
Read more →CVS Executive Says Healthcare Benefits Segment Continues to Underperform But Remain Valuable; Says Challenges Associated With Covid-19 Pandemic, Higher Acuity Levels, And Underestimation Of Medical Cost Exacerbated Utilization Pressures
CVSNovember 6, 2024
Read more →CVS Health Q3 2024 Adj. EPS $1.09 Misses $1.53 Estimate, Sales $95.428B Beat $92.747B Estimate
CVSNovember 6, 2024
Read more →Dow, Nasdaq Jump Over 1% Ahead Of Election Results: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
CVSNovember 6, 2024
Read more →CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
CVSNovember 6, 2024
Read more →CVS Health Q3 Earnings Preview: Can The Company Overcome Recent Challenges?
CVSCVS Health is preparing to report Q3 earnings after cutting its annual profit guidance and implementing leadership changes.
November 4, 2024
Read more →Wells Fargo Maintains Equal-Weight on CVS Health, Lowers Price Target to $60
CVSNovember 4, 2024
Read more →Market Whales and Their Recent Bets on CVS Options
CVSMay 21, 2024
Read more →Market Whales and Their Recent Bets on CVS Options
CVSMay 17, 2024
Read more →